NextCure Inc (NXTC)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $30.59M
Last updated: Nov 17, 2026 at 4:10 PM ET
NextCure Inc (NXTC) Statistics
NextCure (NXTC) has a market cap of $30.59M and an enterprise value of $21.86M. Its share count is up 98.41% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.
Total Valuation
Enterprise value is 28.53% below the market cap, as cash exceeds debt.
| Market Cap | $30.59M |
|---|---|
| Enterprise Value | $21.86M |
| Latest price (Nov 17, 2026) | $6.70 |
Key Dates
The next earnings report is expected on Mar 3, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 3, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 10, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is down 32.19% over 52 weeks and trades 12.98% above its 50-day average.
| Beta (1Y) | 2.18 |
|---|---|
| 52-Week Change | -32.19% |
| 1-Month Change | +18.17% |
| 3-Month Change | -1.18% |
| 6-Month Change | -26.62% |
| 5-Year Change | -93.61% |
| Total Return (1Y) | -32.19% |
| Total Return (3Y CAGR) | -24.16% |
| Total Return (5Y CAGR) | -37.57% |
| Return vs SPY (1Y) | -44.56% |
| Max Drawdown (1Y) | -88.79% |
| Max Drawdown (3Y) | -94.65% |
| Sharpe Ratio (1Y) | -0.24 |
| Correlation with SPY (1Y) | 0.18 |
| 50-Day Average | $5.93 |
| 200-Day Average | $7.49 |
| 52-Week Range | $1.55 to $15.74 |
| RSI (14 Days) | 58.2 |
| Average Volume (20 Days) | 57.07K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.31x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 2.31x |
|---|---|
| Quick Ratio | 2.31x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -744.50% over the last 12 months, against a 5-year average of -74.80%.
| Return on Equity (ROE) | -744.50% |
|---|---|
| Return on Assets (ROA) | -422.37% |
| Return on Capital Employed (ROCE) | -744.50% |
| ROE (5Y Average) | -74.80% |
| ROA (5Y Average) | -59.66% |
Scores
NXTC has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 1 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Revenue Growth (YoY) | -100.00% |
| Gross Profit | -$365.00K |
| Operating Income | -$41.88M |
| Pretax Income | -$40.97M |
| Net Income | -$40.97M |
| EBITDA | -$40.21M |
| EBIT | -$40.97M |
| Reported EPS (TTM) | -$6.19 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 56.70% of the $9.70M in total assets.
| Cash and Equivalents | $8.73M |
|---|---|
| Total Debt | $0 |
| Net Cash | $8.73M |
| Net Cash Per Share | $1.64 |
| Working Capital | $5.50M |
| Shareholder Equity | $5.50M |
| Book Value Per Share | $1.04 |
| Total Assets | $9.70M |
| Total Liabilities | $4.20M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$42.79M |
|---|---|
| FCF Per Share | -$9.34 |
| Depreciation and Amortization | $1.08M |
Trailing 12 months through Sep 30, 2026.
Growth
| Book Value Per Share Growth (2Y CAGR) | -54.99% |
|---|---|
| Tangible Book Per Share Growth (2Y CAGR) | -54.99% |
Dividends and Yields
NXTC does not pay a dividend.
| Buyback Yield | -66.19% |
|---|---|
| Shareholder Yield | -66.19% |
Stock Splits
The last split was a 1-for-12 reverse split on Jul 14, 2025.
| Last Split Date | Jul 14, 2025 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:12 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About NXTC
What is NXTC's market cap?
NextCure has a market cap of $30.59M. Its enterprise value, which adds debt and subtracts cash, is $21.86M.
How many shares of NXTC are outstanding?
NextCure has 5.31M shares outstanding. The count is up 98.41% from a year earlier.
Does NXTC pay a dividend?
No. NextCure does not pay a dividend.
How much debt does NXTC have?
NextCure has $0 of total debt and $8.73M of cash and equivalents, a net cash position of $8.73M.
NXTC pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors